Abraxis BioScience, LLC

États‑Unis d’Amérique


 
Quantité totale PI 208
Rang # Quantité totale PI 6 250
Note d'activité PI 2,4/5.0    33
Rang # Activité PI 23 355
Parent Celgene Corporation
Classe Nice dominante Produits pharmaceutiques, vétéri...

Brevets

Marques

75 8
35 3
79 7
1
 
Dernier brevet 2025 - Biomarkers for nanoparticle comp...
Premier brevet 1987 - Liquid cisplatin formulations
Dernière marque 2017 - ABRAXANE
Première marque 1995 - ANDRAXAN

Industrie (Classification de Nice)

Derniers inventions, produits et services

2025 Invention Biomarkers for nanoparticle compositions. The present invention provides methods and composition...
2024 Invention Methods of treating central nervous system disorders via administration of nanoparticles of an mt...
2023 Invention Methods of treating hematological malignancy using nanoparticle mtor inhibitor combination therap...
Invention Nanoparticle comprising rapamycin and albumin as anticancer agent. The present invention feature...
Invention Methods of treating colon cancer using nanoparticle mtor inhibitor combination therapy. The pres...
2022 Invention Biomarkers for nanoparticle compositions. The present application provides methods and compositi...
Invention Pharmaceutical compositions of albumin and rapamycin. The present invention provides composition...
Invention Methods of assessing suitability of use of pharmaceutical compositions of albumin and poorly wate...
Invention Methods of treating solid tumors using nanoparticle mtor inhibitor combination therapy. The pres...
2021 Invention Methods of treating epithelioid cell tumors. The present invention provides methods and compositi...
2020 Invention Methods and compositions for treating pulmonary hypertension. The present invention features met...
Invention Methods and compositions for treating pulmonary hypertension. The present applications provides ...
Invention Biomarkers for nanoparticle compositions. The present application provides methods and compositio...
Invention Pharmaceutical compositions of albumin and rapamycin. The present invention provides compositions...
Invention Intravascular delivery of nanoparticle compositions and uses thereof. The present invention prov...
Invention Subcutaneous administration of nanoparticles comprising an mtor inhibitor and albumin for treatme...
Invention Combinations and modes of administration of therapeutic agents and combination therapy. The pres...
2019 Invention Combination therapy comprising nanoparticles of a taxane and albumin with abt-263 in methods for ...
Invention Methods of treating bladder cancer. The present invention provides methods and compositions for ...
Invention Methods of assessing suitability of use of pharmaceutical compositions of albumin and paclitaxel....
Invention Methods and compositions for treating pulmonary hypertension. The present applications provides m...
Invention Methods and compositions for treating pulmonary hypertension. e.ge.ge.ge.ge.ge.g., an albumin).
Invention Methods of treating cancer. The present invention provides methods and compositions for treating...
Invention Compositions comprising poorly water soluble pharmaceutical agents and antimicrobial agents. The...
2018 Invention Methods of treating colon cancer using nanoparticle mtor inhibitor combination therapy. The prese...
Invention Nanoparticle compositions of albumin and paclitaxel. The present invention provides compositions...
Invention Combination therapy methods for treating proliferative diseases. The present invention provides ...
2017 Invention Nanoparticle formulations and methods of making and using thereof. The present invention provide...
Invention Methods of treating biliary tract cancer. The present invention provides methods and composition...
Invention Methods of treating mitochondrial and metabolic disorders. The present invention relates to meth...
Invention Methods for assessing neoadjuvant therapies. Therapies compared in clinical studies can he asses...
P/S Injectable pharmaceutical for the treatment of cancer.
2016 P/S Pharmaceuticals for the treatment of cancer.
2011 P/S Pharmaceutical preparations for the treatment of cancer.
2010 P/S Pharmaceutical for the treatment of cancer. Injectable pharmaceutical for the treatment of cancer.
2006 P/S Pharmaceuticals, namely, oncolytics; pharmaceuticals for the treatment of cancer; [ pharmaceutica...
P/S medical and pharmaceutical information services [; medical and pharmaceutical consultation servic...
P/S Pharmaceuticals, namely, oncolytics; pharmaceuticals for the treatment of cancer; pharmaceuticals...
2005 P/S Pharmaceuticals for the treatment of cancer. Research and development in the field of pharmaceuti...
P/S Medical information services in connection with cancer, cancer treatment and new advances in canc...
2004 P/S Pharmaceutical for the treatment of cancer.
P/S Pharmaceutical for the treatment of cancer.
P/S Pharmaceutical for the treatment of cancer
2003 P/S Pharmaceuticals for the treatment of cancer research and development in the field of pharmaceutic...
P/S Injectable pharmaceutical for the treatment of cancer
1995 P/S Proprietary medicine for prostate treatment.